Use this URL to cite or link to this record in EThOS: http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.650348
Title: A synthetic biology approach to metabolic pathway engineering
Author: Merrick, Christine
ISNI:       0000 0004 5356 4002
Awarding Body: University of Glasgow
Current Institution: University of Glasgow
Date of Award: 2015
Availability of Full Text:
Access through EThOS:
Full text unavailable from EThOS. Thesis embargoed until 18 May 2020
Access through Institution:
Abstract:
Microbial biosynthesis of commodity compounds offers a cheaper, greener and more reliable method of production than does chemical synthesis. However, engineering metabolic pathways within a microbe for biosynthesis of a target compound is a complicated process: levels of gene expression, protein stability, enzyme activity, and metabolic flux must be balanced for high productivity without compromising host cell viability. A major rate-limiting step in engineering microbes for optimum biosynthesis of a target compound is DNA assembly, as current methods can be cumbersome and costly. This study aimed to develop a new, synthetic biology tool for rapid DNA assembly that can be applied to engineering and optimizing metabolic pathways for the microbial biosynthesis of commodity compounds. The potential of using serine site-specific recombinases as synthetic biology tools to assemble DNA was investigated and a new DNA assembly method, Serine Integrase Recombinational Assembly (SIRA), using PhiC31 integrase was established. It was demonstrated that SIRA can clone DNA parts ranging in size from 71 bp to 12.7 kb, assemble as many as five DNA parts in a one-pot reaction, facilitate targeted post-assembly modification of an assembled construct and generate variation between DNA constructs in a single assembly reaction. SIRA was used to generate variation between constructs containing genes of the violacein biosynthesis pathway, the lycopene biosynthesis pathway, or the DXP pathway for isoprenoid biosynthesis in E. coli. By studying the phenotypes and genotypes of the constructs generated, it was possible to identify rate-limiting steps within these pathways. Finally, a lycopene-producing in vivo biosensor screen was developed in E. coli to screen DNA assemblies, made with SIRA, encoding genes from the DXP pathway, for enhanced isoprenoid production. By optimizing the expression conditions for assemblies of DXP pathway genes that enhanced isoprenoid production and genes for lycopene biosynthesis in E. coli, 35.78 mg lycopene per gram dry cell weight was obtained - the highest recorded level of lycopene produced from engineering of the DXP pathway alone in E. coli.
Supervisor: Not available Sponsor: Not available
Qualification Name: Thesis (Ph.D.) Qualification Level: Doctoral
EThOS ID: uk.bl.ethos.650348  DOI: Not available
Keywords: QH301 Biology
Share: